Clarksville, TN Online: News, Opinion, Arts & Entertainment.


Topic: Division of Cardiovascular and Renal Products

FDA approves Eliquis to reduce the risk of stroke, blood clots in patients with non-valvular atrial fibrillation

 

Washington, D.C.U.S. Food and Drug Administration - FDAThe U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.

Atrial fibrillation, one of the most common types of abnormal heart rhythm, is an abnormal, irregular, and rapid beating of the heart in which the heart’s two upper chambers (atria) do not contract properly, allowing blood clots to form in them. These clots can break off and travel to the brain or other parts of the body.  «Read the rest of this article»

Sections: News | No Comments
 



Personal Controls

Archives

    October 2014
    S M T W T F S
    « Sep    
     1234
    567891011
    12131415161718
    19202122232425
    262728293031